Prostate Cancer Therapeutics Market Report 2026
Download Free Sample Buy Now
Prostate Cancer Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Prostate Cancer Therapeutics Market Report 2026

Global Outlook – By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Other Therapies), By Drug Class (Androgen Receptor Inhibitors, GnRH Receptor Antagonists, PARP Inhibitors, Immune Checkpoint Inhibitors, Other Drug Classes), By Route Of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End User (Clinics, Hospitals, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Prostate Cancer Therapeutics Market Overview

• Prostate Cancer Therapeutics market size has reached to $12.88 billion in 2025

• Expected to grow to $19.25 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%

• Growth Driver: Surge In Prostate Cancer Incidences Fueling The Growth Of The Market Due To Aging Population And Increased Life Expectancy

• Market Trend: Launch Of India's First Oral Once-A-Day Pill For Advanced Prostate Cancer

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Prostate Cancer Therapeutics Market?

Prostate cancer therapeutics refer to the range of medical treatments and interventions used to manage, control, or eliminate prostate cancer, a type of cancer that develops in the prostate gland of men. These therapies aim to slow disease progression, relieve symptoms, improve quality of life, and, in some cases, achieve remission.

The main types of therapies in prostate cancer therapeutics are hormonal therapy, chemotherapy, immunotherapy, targeted therapy, and others. Hormonal therapy is a medical treatment that alters hormone levels in the body to manage or treat certain conditions, like cancer or hormonal imbalances. It includes various drug classes such as androgen receptor inhibitors, GnRH receptor antagonists, PARP inhibitors, immune checkpoint inhibitors, and others administered orally or through injection. These therapies are distributed through hospital pharmacies, retail pharmacies, and online sales, catering to various end users such as clinics, hospitals, and others.

Prostate Cancer Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Prostate Cancer Therapeutics Market Size and Share 2026?

The prostate cancer therapeutics market size has grown strongly in recent years. It will grow from $12.88 billion in 2025 to $13.96 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising prostate cancer incidence, aging male population, advancements in oncology drugs, hospital-based cancer care, increased cancer screening.

What Is The Prostate Cancer Therapeutics Market Growth Forecast?

The prostate cancer therapeutics market size is expected to see strong growth in the next few years. It will grow to $19.25 billion in 2030 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to precision oncology adoption, biomarker-driven therapies, growth in oral oncology drugs, expanding immunotherapy pipeline, rising healthcare expenditure. Major trends in the forecast period include growing adoption of targeted therapies, rising use of parp inhibitors, expansion of immunotherapy in oncology, shift toward oral cancer drugs, precision medicine-based treatment selection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Prostate Cancer Therapeutics Market Segmentation

1) By Therapy: Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Other Therapies

2) By Drug Class: Androgen Receptor Inhibitors, GnRH Receptor Antagonists, PARP Inhibitors, Immune Checkpoint Inhibitors, Other Drug Classes

3) By Route Of Administration: Oral, Injectable

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies

5) By End User: Clinics, Hospitals, Other End Users

Subsegments:

1) By Hormonal Therapy: Luteinizing Hormone-Releasing Hormone (LHRH) Agonists, LHRH Antagonists, Anti-Androgens, Androgen Synthesis Inhibitors

2) By Chemotherapy: Docetaxel, Cabazitaxel, Mitoxantrone, Combination Chemotherapy Regimens

3) By Immunotherapy: Sipuleucel-T, Immune Checkpoint Inhibitors, Cancer Vaccines

4) By Targeted Therapy: PARP Inhibitors, Radioligand Therapy

5) By Other Therapies: Radiotherapy, Bone-Targeted Therapies, Cryotherapy, High-Intensity Focused Ultrasound

What Is The Driver Of The Prostate Cancer Therapeutics Market?

The increasing incidence of prostate cancer is expected to propel the growth of the prostate cancer therapeutics market going forward. Prostate cancer is a disease in which malignant cells form in the tissues of the prostate gland, typically affecting older men. The incidence of prostate cancer is increasing due to the aging population, as the risk of developing the disease rises significantly with age, and longer life expectancy leads to more men living long enough to create it. Prostate cancer therapeutics help manage the disease by targeting cancer cells, slowing progression, and improving quality of life through treatments such as surgery, radiation, hormone therapy, and newer options like immunotherapy. For instance, in January 2025, according to Prostate Cancer UK, a UK-based nonprofit cancer research and advocacy organization, the number of men diagnosed with prostate cancer increased from 50,751 cases in 2022 to 55,033 cases in 2023. Therefore, the increasing incidence of prostate cancer is driving the growth of the prostate cancer therapeutics industry.

Key Players In The Global Prostate Cancer Therapeutics Market

Major companies operating in the prostate cancer therapeutics market are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Astellas Pharma Inc., Jiangsu Hengrui Medicine Co. Ltd., Telix Pharmaceuticals, Bayer AG, Curium Pharma SAS, Dendreon Pharmaceuticals, Myovant Sciences GmbH, Clovis Oncology Inc., Ipsen S.A., Veru Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Dendreon Pharmaceuticals LLC, Pfizer Inc., Ferring B.V.

Global Prostate Cancer Therapeutics Market Trends and Insights

Major companies operating in the prostate cancer therapeutics market are focusing on advancing innovative therapeutics, such as an oral once-a-day pill for advanced prostate cancer, to improve patient compliance and overall treatment outcomes. The oral once-a-day pill for advanced prostate cancer refers to treatments that are taken daily to manage metastatic castration-resistant prostate cancer by inhibiting testosterone's effects on cancer cells. For instance, in January 2024, Zydus Lifesciences, an India-based company, launched Rexigo, India's first oral once-a-day pill containing relugolix for advanced prostate cancer patients. This convenient and affordable alternative to injectable hormone therapies rapidly suppresses testosterone, helping control cancer growth while offering a better cardiovascular safety profile. It is an oral therapy, eliminating the need for injectable treatments that require administration by healthcare providers, thus offering greater patient convenience. This launch represents a significant advancement in prostate cancer management in India, providing patients and doctors with a new, convenient, safe, cost-effective treatment option.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Prostate Cancer Therapeutics Market?

In June 2024, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, acquired Fusion Pharmaceuticals Inc. for an undisclosed amount. With this acquisition, AstraZeneca aims to accelerate the development of next-generation radio conjugates to transform cancer treatment by delivering more targeted therapies that can replace traditional chemotherapy and radiotherapy regimens. Fusion Pharmaceuticals is a Canada-based clinical-stage oncology company that offers prostate cancer therapies, specifically targeting metastatic castration-resistant prostate cancer (mCRPC).

Regional Insights

North America was the largest region in the prostate cancer therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prostate Cancer Therapeutics Market?

The prostate cancer therapeutics market consists of revenues earned by entities by providing services such as medical consultation services, diagnostic services, psychosocial support, clinical trials access, and genetic counseling and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The prostate cancer therapeutics market also includes sales of hormone therapy medications, chemotherapy drugs, immunotherapy products, and targeted therapy drugs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Prostate Cancer Therapeutics Market Report 2026?

The prostate cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prostate cancer therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Prostate Cancer Therapeutics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $13.96 billion
Revenue Forecast In 2035 $19.25 billion
Growth Rate CAGR of 8.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Therapy, Drug Class, Route Of Administration, Distribution Channel, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Astellas Pharma Inc., Jiangsu Hengrui Medicine Co. Ltd., Telix Pharmaceuticals, Bayer AG, Curium Pharma SAS, Dendreon Pharmaceuticals, Myovant Sciences GmbH, Clo
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Prostate Cancer Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Prostate Cancer Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Prostate Cancer Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Prostate Cancer Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Growing Adoption Of Targeted Therapies

4.2.2 Rising Use Of Parp Inhibitors

4.2.3 Expansion Of Immunotherapy In Oncology

4.2.4 Shift Toward Oral Cancer Drugs

4.2.5 Precision Medicine-Based Treatment Selection

5. Prostate Cancer Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Clinics

5.3 Specialty Cancer Centers

5.4 Retail Pharmacies

5.5 Online Pharmacies

6. Prostate Cancer Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Prostate Cancer Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Prostate Cancer Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Prostate Cancer Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Prostate Cancer Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Prostate Cancer Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Prostate Cancer Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Prostate Cancer Therapeutics Market Segmentation

9.1. Global Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy, Other Therapies

9.2. Global Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Androgen Receptor Inhibitors, GnRH Receptor Antagonists, PARP Inhibitors, Immune Checkpoint Inhibitors, Other Drug Classes

9.3. Global Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable

9.4. Global Prostate Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies

9.5. Global Prostate Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinics, Hospitals, Other End Users

9.6. Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Luteinizing Hormone-Releasing Hormone (LHRH) Agonists, LHRH Antagonists, Anti-Androgens, Androgen Synthesis Inhibitors

9.7. Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Docetaxel, Cabazitaxel, Mitoxantrone, Combination Chemotherapy Regimens

9.8. Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Sipuleucel-T, Immune Checkpoint Inhibitors, Cancer Vaccines

9.9. Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PARP Inhibitors, Radioligand Therapy

9.10. Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Radiotherapy, Bone-Targeted Therapies, Cryotherapy, High-Intensity Focused Ultrasound

10. Prostate Cancer Therapeutics Market Regional And Country Analysis

10.1. Global Prostate Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Prostate Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Prostate Cancer Therapeutics Market

11.1. Asia-Pacific Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Prostate Cancer Therapeutics Market

12.1. China Prostate Cancer Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Prostate Cancer Therapeutics Market

13.1. India Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Prostate Cancer Therapeutics Market

14.1. Japan Prostate Cancer Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Prostate Cancer Therapeutics Market

15.1. Australia Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Prostate Cancer Therapeutics Market

16.1. Indonesia Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Prostate Cancer Therapeutics Market

17.1. South Korea Prostate Cancer Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Prostate Cancer Therapeutics Market

18.1. Taiwan Prostate Cancer Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Prostate Cancer Therapeutics Market

19.1. South East Asia Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Prostate Cancer Therapeutics Market

20.1. Western Europe Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Prostate Cancer Therapeutics Market

21.1. UK Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Prostate Cancer Therapeutics Market

22.1. Germany Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Prostate Cancer Therapeutics Market

23.1. France Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Prostate Cancer Therapeutics Market

24.1. Italy Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Prostate Cancer Therapeutics Market

25.1. Spain Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Prostate Cancer Therapeutics Market

26.1. Eastern Europe Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Prostate Cancer Therapeutics Market

27.1. Russia Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Prostate Cancer Therapeutics Market

28.1. North America Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Prostate Cancer Therapeutics Market

29.1. USA Prostate Cancer Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Prostate Cancer Therapeutics Market

30.1. Canada Prostate Cancer Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Prostate Cancer Therapeutics Market

31.1. South America Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Prostate Cancer Therapeutics Market

32.1. Brazil Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Prostate Cancer Therapeutics Market

33.1. Middle East Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Prostate Cancer Therapeutics Market

34.1. Africa Prostate Cancer Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Prostate Cancer Therapeutics Market, Segmentation By Therapy, Segmentation By Drug Class, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Prostate Cancer Therapeutics Market Regulatory and Investment Landscape

36. Prostate Cancer Therapeutics Market Competitive Landscape And Company Profiles

36.1. Prostate Cancer Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Prostate Cancer Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Prostate Cancer Therapeutics Market Company Profiles

36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. Prostate Cancer Therapeutics Market Other Major And Innovative Companies

Sanofi S.A., Astellas Pharma Inc., Jiangsu Hengrui Medicine Co. Ltd., Telix Pharmaceuticals, Bayer AG, Curium Pharma SAS, Dendreon Pharmaceuticals, Myovant Sciences GmbH, Clovis Oncology Inc., Ipsen S.A., Veru Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Dendreon Pharmaceuticals LLC, Pfizer Inc.

38. Global Prostate Cancer Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Prostate Cancer Therapeutics Market

40. Prostate Cancer Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Prostate Cancer Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Prostate Cancer Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Prostate Cancer Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Prostate Cancer Therapeutics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Prostate Cancer Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Prostate Cancer Therapeutics Market, Supply Chain Analysis
  • Table 4: Global Prostate Cancer Therapeutics Market, Major Raw Material Providers
  • Table 5: Global Prostate Cancer Therapeutics Market, Major Resource Providers
  • Table 6: Global Prostate Cancer Therapeutics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Prostate Cancer Therapeutics Market, Major Distributors And Channel Partners
  • Table 8: Global Prostate Cancer Therapeutics Market, Key Technologies & Future Trends
  • Table 9: Global Prostate Cancer Therapeutics Market, Major Trends
  • Table 10: Global Prostate Cancer Therapeutics Market, Major End Users
  • Table 11: Global Prostate Cancer Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Prostate Cancer Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Prostate Cancer Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Prostate Cancer Therapeutics Market - TAM, US$ Billion, 2025
  • Table 15: Global Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Prostate Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Prostate Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Prostate Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Prostate Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Prostate Cancer Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Prostate Cancer Therapeutics Market - Company Scoring Matrix
  • Table 101: Johnson & Johnson Financial Performance
  • Table 102: Merck & Co. Inc. Financial Performance
  • Table 103: AbbVie Inc. Financial Performance
  • Table 104: Novartis AG Financial Performance
  • Table 105: AstraZeneca plc Financial Performance
  • Table 106: Global Prostate Cancer Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Prostate Cancer Therapeutics Market, Competitive Dashboard
  • Table 108: Global Prostate Cancer Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Prostate Cancer Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Table 110: Global, Prostate Cancer Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Table 111: Global, Prostate Cancer Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Prostate Cancer Therapeutics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Prostate Cancer Therapeutics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Prostate Cancer Therapeutics Market, Supply Chain Analysis
  • Figure 4: Global Prostate Cancer Therapeutics Market, Major Raw Material Providers
  • Figure 5: Global Prostate Cancer Therapeutics Market, Major Resource Providers
  • Figure 6: Global Prostate Cancer Therapeutics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Prostate Cancer Therapeutics Market, Major Distributors And Channel Partners
  • Figure 8: Global Prostate Cancer Therapeutics Market, Key Technologies & Future Trends
  • Figure 9: Global Prostate Cancer Therapeutics Market, Major Trends
  • Figure 10: Global Prostate Cancer Therapeutics Market, Major End Users
  • Figure 11: Global Prostate Cancer Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Prostate Cancer Therapeutics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Prostate Cancer Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Prostate Cancer Therapeutics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Prostate Cancer Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Prostate Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Chemotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Targeted Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Prostate Cancer Therapeutics Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Prostate Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Prostate Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Prostate Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Prostate Cancer Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Prostate Cancer Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Prostate Cancer Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Prostate Cancer Therapeutics Market - Company Scoring Matrix
  • Figure 101: Johnson & Johnson Financial Performance
  • Figure 102: Merck & Co. Inc. Financial Performance
  • Figure 103: AbbVie Inc. Financial Performance
  • Figure 104: Novartis AG Financial Performance
  • Figure 105: AstraZeneca plc Financial Performance
  • Figure 106: Global Prostate Cancer Therapeutics Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Prostate Cancer Therapeutics Market, Competitive Dashboard
  • Figure 108: Global Prostate Cancer Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Prostate Cancer Therapeutics Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030
  • Figure 110: Global, Prostate Cancer Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Class, 2025 – 2030
  • Figure 111: Global, Prostate Cancer Therapeutics Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Prostate Cancer Drugs Market Report 2026 - Global Outlook – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), B...

Metastatic Cancer Drugs Market Report 2026 - Global Outlook – By Drug Class (HER2 Inhibitors, Immune Checkpoints Inhibitors, PARP Inhibitors, Kinase Inhibitors, Other Drug Class), By Cancer (Breast Cancer, Lung Cancer, L...

Urothelial Cancer Drugs Market Report 2026 - Global Outlook – By Type (Urothelial Carcinoma, Squamous Cell Carcinoma, Adenocarcinoma), By Treatment (Immunotherapy, Chemotherapy, Preservation Therapy), By Distribution Cha...

Drugs For Benign Prostatic hypertrophy Market Report 2026 - Global Outlook – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies,...

Bladder Cancer Drugs Market Report 2026 - Global Outlook – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hosp...

Prostate Cancer Nuclear Medicine Diagnostics Market Report 2026 - Global Outlook – By Type (Single Photon Emission Computed Tomography (SPECT), Photon Emission Computed Tomography (PET)), By Test Type (Preliminary Tests,...

Pet Cancer Therapeutics Market Report 2026 - Global Outlook – By Cancer Type (Melanoma, Mast Cell Cancer, Lymphoma, Mammary And Squamous Cell Cancer), By Species (Dogs, Cats, Other Species), By Therapy (Chemotherapy, Rad...

Prostate Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell ...

Frequently Asked Questions

The Prostate Cancer Therapeutics market was valued at $12.88 billion in 2025, increased to $13.96 billion in 2026, and is projected to reach $19.25 billion by 2030.

The global Prostate Cancer Therapeutics market is expected to grow at a CAGR of 8.4% from 2026 to 2035 to reach $19.25 billion by 2035.

Some Key Players in the Prostate Cancer Therapeutics market Include, Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Novartis AG, AstraZeneca plc, Sanofi S.A., Astellas Pharma Inc., Jiangsu Hengrui Medicine Co. Ltd., Telix Pharmaceuticals, Bayer AG, Curium Pharma SAS, Dendreon Pharmaceuticals, Myovant Sciences GmbH, Clovis Oncology Inc., Ipsen S.A., Veru Inc., Bristol‑Myers Squibb Company, F. Hoffmann‑La Roche Ltd, Dendreon Pharmaceuticals LLC, Pfizer Inc., Ferring B.V. .

Major trend in this market includes: Launch Of India's First Oral Once-A-Day Pill For Advanced Prostate Cancer. For further insights on this market. request a sample here

North America was the largest region in the prostate cancer therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prostate cancer therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us